MedTrace Logo

A Registry Study of Shuxuening Injection Used in Hospitals in China

NCT01752946 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30000

Last updated 2012-12-20

No results posted yet for this study

Summary

The purpose of this study is get to know what and how Shuxuening injection in hospital results in adverse events or adverse drug reactions from a cohort event monitoring.

Conditions

  • Coronary Disease
  • Intracranial Embolism
  • Stroke
  • Angina Pectoris
  • Vasospasm

Sponsors & Collaborators

  • Beijing University of Chinese Medicine

    collaborator OTHER

  • China Academy of Chinese Medical Sciences

    lead OTHER

Principal Investigators

  • Yan M Xie, BA · Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2015-12-31
Completion
2015-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01752946 on ClinicalTrials.gov